Employees: NN (None)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2015-07-17 (10 years)Status: ActiveBusiness sector: Activités des sièges sociauxLocation: NANGIS (77370), Seine-et-Marne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS : revenue, balance sheet and financial ratios
FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS is a French company
founded 10 years ago,
specialized in the sector Activités des sièges sociaux.
Based in NANGIS (77370),
this company of category PME
shows in 2023 a net income positive of 265 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS (SIREN 812648905)
Indicator
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
265 314 €
196 300 €
81 798 €
98 087 €
129 664 €
91 100 €
71 554 €
-101 192 €
EBITDA
N/C
N/C
N/C
N/C
-3 237 €
-4 751 €
-5 488 €
-88 609 €
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS generates positive net income of 265 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
265 314 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 116%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 44%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
116.29%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
44.38%
Solvency indicators evolution FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Debt ratio
-1604.2
4013.049
634.309
273.115
244.927
208.869
153.85
116.29
Financial autonomy
-6.648
2.431
13.386
26.801
28.992
32.238
37.952
44.38
Repayment capacity
-8.115
11.42
7.761
5.079
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
116.292023
2021
2022
2023
Q1: 0.15
Med: 18.69
Q3: 101.54
Average
In 2023, the debt ratio of FINANCIERE DE PHARMACIE P... (116.29) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
44.38%2023
2021
2022
2023
Q1: 13.72%
Med: 51.34%
Q3: 84.19%
Average+11 pts over 3 years
In 2023, the financial autonomy of FINANCIERE DE PHARMACIE P... (44.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 68.71. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
68.708
Liquidity indicators evolution FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
Liquidity ratio
None
None
469.601
None
None
694.354
256.025
68.708
Interest coverage
-14.201
-236.133
-255.736
-342.601
None
None
None
None
Sector positioning
Liquidity ratio
68.712023
2021
2022
2023
Q1: 110.3
Med: 414.17
Q3: 1926.34
Average-34 pts over 3 years
In 2023, the liquidity ratio of FINANCIERE DE PHARMACIE P... (68.71) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS in its sector
Comparison with sector Activités des sièges sociaux
Valuation estimate
Based on 89 transactions of similar company sales
in 2023,
the value of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS is estimated at
1 786 798 €
(range 851 210€ - 4 119 691€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate. Medium reliability: estimate to be confirmed with in-depth analysis.
Estimated enterprise value2023
89 tx
851k€1786k€4119k€
1 786 798 €Range: 851 210€ - 4 119 691€
NAF 5 année 2023
Valuation method used
Net Income Multiple
265 314 €
×
6.7x
=1 786 798 €
Range: 851 211€ - 4 119 691€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 89 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Activités des sièges sociaux)
Compare FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS with other companies in the same sector:
Frequently asked questions about FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS
What is the revenue of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS ?
The revenue of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS is not publicly disclosed (confidential accounts filed with INPI).
Is FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS profitable?
Yes, FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS generated a net profit of 265 k€ in 2023.
Where is the headquarters of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS ?
The headquarters of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS is located in NANGIS (77370), in the department Seine-et-Marne.
Where to find the tax return of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS ?
The tax return of FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS operate?
FINANCIERE DE PHARMACIE PRINCIPALE DE NANGIS operates in the sector Activités des sièges sociaux (NAF code 70.10Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart